Neogen Corporation Line of Credit Facility, Maximum Borrowing Capacity
Neogen Corporation (NEOG) had Line of Credit Facility, Maximum Borrowing Capacity of $15.00 million as of 2024-05-31, per its 10-K filed 2024-07-30.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2024-07-30
- 2024-05-31: Line of Credit Facility, Maximum Borrowing Capacity $15.00M.
- 2024-02-29: Line of Credit Facility, Maximum Borrowing Capacity $15.00M.
- 2023-11-30: Line of Credit Facility, Maximum Borrowing Capacity $15.00M.
- 2023-08-31: Line of Credit Facility, Maximum Borrowing Capacity $15.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2024-05-31 | $15.00M 10-K · filed 2024-07-30 |
| 2024-02-29 | $15.00M 10-Q · filed 2024-04-09 |
| 2023-11-30 | $15.00M 10-Q · filed 2024-01-09 |
| 2023-08-31 | $15.00M 10-Q · filed 2023-10-10 |
| 2023-05-31 | $15.00M 10-K · filed 2023-08-15 |
| 2023-02-28 | $15.00M 10-Q · filed 2023-04-04 |
| 2022-11-30 | $15.00M 10-Q · filed 2023-01-09 |
| 2022-08-31 | $15.00M 10-Q · filed 2022-09-30 |
| 2022-05-31 | $15.00M 10-K · filed 2022-07-27 |
| 2022-02-28 | $15.00M 10-Q · filed 2022-04-01 |
| 2021-11-30 | $15.00M 10-Q · filed 2021-12-30 |
| 2021-08-31 | $15.00M 10-Q · filed 2021-09-30 |
| 2021-05-31 | $15.00M 10-K · filed 2021-07-30 |
| 2021-02-28 | $15.00M 10-Q · filed 2021-03-31 |
| 2020-11-30 | $15.00M 10-Q · filed 2020-12-29 |
| 2020-08-31 | $15.00M 10-Q · filed 2020-09-30 |
| 2020-05-31 | $15.00M 10-K · filed 2020-07-30 |
| 2019-11-30 | $15.00M 10-Q · filed 2020-04-03 |
| 2019-08-31 | $15.00M 10-Q · filed 2019-09-26 |
| 2019-02-28 | $15.00M 10-Q · filed 2019-03-29 |
| 2018-11-30 | $15.00M 10-K · filed 2019-07-30 |
| 2018-08-31 | $15.00M 10-Q · filed 2018-10-05 |
| 2018-05-31 | $15.00M 10-K · filed 2018-07-27 |
| 2018-02-28 | $15.00M 10-Q · filed 2018-03-29 |
| 2017-11-30 | $15.00M 10-Q · filed 2018-01-05 |
| 2017-08-31 | $15.00M 10-Q · filed 2017-09-29 |
| 2017-05-31 | $15.00M 10-K · filed 2017-07-28 |
| 2017-02-28 | $15.00M 10-Q · filed 2017-03-31 |
| 2016-11-30 | $15.00M 10-Q · filed 2016-12-29 |
| 2016-11-29 | $12.00M 10-Q · filed 2018-10-05 |
| 2016-08-31 | $12.00M 10-Q · filed 2016-09-30 |
| 2016-05-31 | $12.00M 10-K · filed 2016-07-29 |
| 2016-02-29 | $12.00M 10-Q · filed 2016-03-31 |
| 2015-11-30 | $12.00M 10-Q · filed 2016-01-08 |
| 2015-08-31 | $12.00M 10-Q · filed 2015-09-30 |
| 2015-05-31 | $12.00M 10-K · filed 2015-07-30 |
| 2015-02-28 | $12.00M 10-Q · filed 2015-04-01 |
| 2014-11-30 | $12.00M 10-Q · filed 2014-12-30 |
| 2014-08-31 | $12.00M 10-Q · filed 2014-09-30 |
| 2014-05-30 | $12.00M 10-K · filed 2014-07-30 |
| 2014-02-28 | $12.00M 10-Q · filed 2014-04-04 |
| 2013-11-30 | $12.00M 10-Q · filed 2014-01-09 |
| 2013-08-31 | $12.00M 10-Q · filed 2013-09-30 |
| 2013-05-31 | $12.00M 10-K · filed 2013-07-30 |
| 2013-02-28 | $12.00M 10-Q · filed 2013-03-28 |
| 2012-11-30 | $12.00M 10-Q · filed 2012-12-28 |
| 2012-08-31 | $12.00M 10-Q · filed 2012-09-28 |
| 2012-05-31 | $12.00M 10-K · filed 2012-07-30 |
| 2012-02-29 | $10.00M 10-Q · filed 2012-03-30 |
| 2011-11-30 | $10.00M 10-Q · filed 2011-12-30 |
| 2011-08-31 | $10.00M 10-Q · filed 2011-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |